Why is Nectar Lifesci. falling/rising?

As of 01-Jul, Nectar Lifescience Ltd's stock price is currently at 22.85, reflecting an increase of 0.68 or 3.07%. Today's performance indicates a trend reversal as the stock has gained after two consecutive days of decline and has outperformed its sector by 3.28%. However, despite this short-term gain, the stock has shown a significant decline of 15.40% over the past month and a staggering 41.41% year-to-date. Positive factors contributing to the recent price movement include a 40% growth in net profit and consistent positive results over the last six quarters, alongside an attractive valuation compared to peers. Conversely, the stock faces challenges such as weak long-term fundamentals, a high debt-to-EBITDA ratio, and a concerning 99.6% of promoter shares being pledged, which could exert downward pressure on the stock.
In the broader market context, Nectar Lifescience's short-term return of 8.81% over the past week significantly outpaces the Sensex, which has only increased by 2.00% during the same period. However, the stock's long-term performance remains underwhelming, with a one-year return of -27.90%, indicating that while there may be short-term gains, the overall trend has been negative compared to the benchmark. This juxtaposition highlights the stock's volatility and the potential for investor caution given its long-term underperformance and the high level of pledged shares.